Literature DB >> 6398935

Graves' eye disease: orbital compliance and other physical measurements.

B R Frueh.   

Abstract

Entities:  

Mesh:

Year:  1984        PMID: 6398935      PMCID: PMC1298676     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  45 in total

1.  The difference in exophthalmometric values on the two eyes in persons with high degree of myopia in one eye.

Authors:  T I BERTELSEN
Journal:  Acta Ophthalmol (Copenh)       Date:  1956

2.  Exophthalmometry.

Authors:  L C DREWS
Journal:  Am J Ophthalmol       Date:  1957-01       Impact factor: 5.258

3.  Strength of the orbicularis oculi.

Authors:  H B JACOBS
Journal:  Br J Ophthalmol       Date:  1954-09       Impact factor: 4.638

4.  Clinical orbitonometry.

Authors:  J H MEANS; J B STANBURY
Journal:  Am J Med Sci       Date:  1950-10       Impact factor: 2.378

5.  Bulbar-pressure tests. Comparison of data obtained with anterior, lateral, and posterior compression of the eyeball.

Authors:  A P Nesterov; E R Davlekamova
Journal:  Arch Ophthalmol       Date:  1974-07

6.  Additional clinical sign of "unilateral" endocrine exophthalamos.

Authors:  J Hauer
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

7.  Topical guanethidine therapy for endocrine lid retraction.

Authors:  A J Gay; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1966-09

8.  Human exophthalmometry.

Authors:  B Tengroth; H Bogren; U Zackrisson
Journal:  Acta Ophthalmol (Copenh)       Date:  1964

9.  Inhibited growth and development as permanent features of low birth weight. A longitudinal study of eye size, height, head circumference, interpupillary distance and exophthalmometry, as measured at age of 10 and 18 years.

Authors:  H C Fledelius
Journal:  Acta Paediatr Scand       Date:  1982-07

10.  Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy.

Authors:  N Shorr; R W Neuhaus; H I Baylis
Journal:  Ophthalmology       Date:  1982-04       Impact factor: 12.079

View more
  12 in total

1.  Levator force generation in normal subjects.

Authors:  B R Frueh; D C Musch
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  Spontaneous reversal of vertical diplopia in Graves' eye disease.

Authors:  B R Frueh; R S Benger
Journal:  Trans Am Ophthalmol Soc       Date:  1985

3.  Upper eyelid retraction in Graves' ophthalmopathy: a new surgical technique and a study of the abnormal levator muscle.

Authors:  R G Small
Journal:  Trans Am Ophthalmol Soc       Date:  1988

Review 4.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

5.  The surface of the corneal graft: in vivo color specular microscopic study in the human.

Authors:  M A Lemp
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 6.  Assessment of Orbital Compartment Pressure: A Comprehensive Review.

Authors:  Tim J Enz; Markus Tschopp
Journal:  Diagnostics (Basel)       Date:  2022-06-16

7.  The Effect of Axial Length on Extraocular Muscle Leverage.

Authors:  Robert A Clark; Joseph L Demer
Journal:  Am J Ophthalmol       Date:  2020-04-02       Impact factor: 5.258

8.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

9.  Clinical pathophysiology of thyroid eye disease: The Cone Model.

Authors:  Paul Meyer; Tilak Das; Nima Ghadiri; Rachna Murthy; Sofia Theodoropoulou
Journal:  Eye (Lond)       Date:  2019-01-18       Impact factor: 3.775

Review 10.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.